comparemela.com

Latest Breaking News On - Astellas venture - Page 1 : comparemela.com

Mogrify extends Series A financing to $46 million USD

Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing.

United kingdomTadayoshi hirataJonathan milnerDarrinm disleyMogrify limitedAbcam plcAstellas pharma incTrend investment groupFrom mogrifyoctAstellas venture managementParkwalk advisorsAhren innovation capitalAstellas pharmaSenior investment managerAstellas ventureHearing loss

Avilar Therapeutics Increases Seed Financing to $75M

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Paulina hillBrian halakDaniel grauAvilar therapeuticsSanofi venturesMedical excellence capitalAstellas venture

NeoPhore completes extension to Series B financing to further advance discovery pipeline

/PRNewswire/ NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces the completion of its £21.5m (US $28.5m) Series B.

United kingdomEast lothianMatthew bakerRobert jamesHelsinn investment fundUniversity of turinElement capitalAstellas venture managementUniversity of londonAstellas pharma incB future health fundPhoremost ltdPioneer fundMemorial sloan kettering cancer centerNeophore limitedClaris ventures

NeoPhore completes extension to Series B financing to further advance discovery pipeline

NeoPhore completes extension to Series B financing to further advance discovery pipeline
prnewswire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomEast lothianMatthew bakerRobert jamesHelsinn investment fundUniversity of turinElement capitalAstellas venture managementUniversity of londonAstellas pharma incB future health fundPhoremost ltdPioneer fundMemorial sloan kettering cancer centerNeophore limitedClaris ventures

Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss

/PRNewswire/ Mogrify Limited (CEO: Darrin M. Disley, Ph.D., "Mogrify®"), a biopharmaceutical company transforming the lives of patients through a novel.

City ofUnited kingdomUnited statesNorth carolinaSouth san franciscoSan franciscoJonathan milnerMathew pletcherLinkedin mogrifyLouise modisDarrinm disleyJ public healthTrend investment groupAstellas pharma incUniversity of bristol enterprise fundZyme communications

vimarsana © 2020. All Rights Reserved.